Eupraxia Pharmaceuticals Inc (EPRX) — Cash Flow Reinvestment Rate
Latest as of March 2020:
0.05x
Eupraxia Pharmaceuticals Inc (EPRX) has a Cash Flow Reinvestment Rate of 0.05x as of March 2020, reinvesting CA$25.31K (capex CA$3.80K plus investments CA$-21.51K) from operating cash flow of CA$503.92K. Explore EPRX cash generation efficiency to assess how effectively this company generates cash.
Reinvestment Rate
0.05x
(Capex + Investments) / Operating CF
Total Reinvested
CA$25.31K
Capex + Investments
Operating Cash Flow
CA$503.92K
CAD
Capital Expenditures
CA$3.80K
CAD
Annual Cash Flow Reinvestment Rate for Eupraxia Pharmaceuticals Inc (None–None)
Year-by-year capital reinvestment analysis for Eupraxia Pharmaceuticals Inc. For live market cap and broader valuation context, see Eupraxia Pharmaceuticals Inc (EPRX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow